Clinical efficacy of doripenem(3g daily)against patients with obstructive pyelonephritis caused by ureteral calculi.

Not Applicable

• Conditions: Obstructive pyelonephritis caused by ureteral calculi.

• Registration Number: JPRN-UMIN000010192
• Lead Sponsor: Jikei university katsushika medical center,Department of urology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1)patient wiht prostatitis or epididymitis. 2)patient with urinary diversion. 3)patient was administered other antimicrobials and their symptom has been improved before starting administration of doripenem. 4)patient with severe underlying disease or complications, who cannot be evaluated efficacy and safety of doripenem. 5)patient with carbapenem allergies. 6)patient with severe cardiac or hepatic dysfunction. 7)patient with moderate renal dysfunction (criteria:serum creatinine>=2mg/dL) 8)patient with convulsive disorders such as epilepsy. 9)Pregnant women or females with childbearing potential. 10)patient disqualified as target by doctor. 11)Doripenem resistant pathogen has been already isolated.

Study & Design

• Study Type: Interventional
• Study Design: Not specified